In this episode, host Dr. Stephen Liu leads a discussion on the current first-line treatment options for EGFR-mutant non-small cell lung cancer, including how new data from FLAURA2 and MARIPOSA may influence treatment approaches.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
